New deals every Friday

Private healthcare & SaaS acquisition signals — before they hire a banker

We surface founder-owned companies showing exit intent 6–12 months before they hit brokers or public marketplaces. Used by PE firms, search funds, and strategic buyers.

Browse deals ↗ See pricing
1,240+
Deals tracked
8 mo.
Avg. signal lead time
34
New this week

How it works

Acquisition intelligence, not listings

Most deal flow platforms show you what's already for sale. We show you what's about to be.

1

Scan 40+ sources

LinkedIn, Hacker News, healthcare publications, job boards, and founder forums — monitored daily for exit signals.

2

AI scoring engine

Every company receives a 1–100 acquisition probability score based on founder language, hiring activity, company age, and revenue signals.

3

Friday digest

3 scored opportunities every Friday — with founder contact info, acquisition thesis, and a suggested outreach script for each.


This week's signals

Pre-market deal flow

A sample of what Pro subscribers received last Friday.

ClearPath RCM RCM
$3M–$6M ARR · 22 employees · Nashville, TN
87
acq. score
Founder succession post Hired fractional CFO Open to conversations

Founder-led RCM firm serving 40+ physician groups. Founder signaling next chapter on LinkedIn — classic pre-sale sequence.

MedStaff Pro Health SaaS
$5M–$10M ARR · 48 employees · Chicago, IL
91
acq. score
Posted M&A advisor role Revenue plateau 18mo Hired investment banker

HRIS platform for travel nursing agencies. Posting for VP Corp Dev and M&A advisory roles strongly signals prep for sale.

██████████ Claims Mgmt
$2M–$4M ARR · 19 employees · Indianapolis, IN
79
acq. score
████████████ ████████

████████████████████████████████████

Pro subscribers only

🔒 Unlock deal
██████████ AI SaaS
$800K–$2M ARR · 6 employees · Remote
68
acq. score
████████████ ████████

████████████████████████████████████

Pro subscribers only

🔒 Unlock deal


How we score

The acquisition probability score

Every company gets a 1–100 score based on 7 signal categories. Here's exactly what goes into it.

Signal category weights

Founder exit language
30 pts
Job posting signals
20 pts
Company & founder age
15 pts
Revenue plateau / decline
15 pts
Leadership changes
10 pts
No recent funding rounds
5 pts
Forum / social activity
5 pts
Total possible 100 pts
80–100 Hot

This company is showing strong exit signals right now. Move quickly — these deals close before most buyers know they exist.

60–79 Warm

Several exit signals detected. Worth reaching out now before the process formally begins.

40–59 Watch

Early-stage signals present. Monitor this company — it may move into Hot or Warm territory within 90 days.

0–39 Cold

No clear exit signals detected at this time. Not yet a deal worth pursuing.

Why this matters to buyers

A company scoring 80+ is typically 6–12 months from hiring a banker. Gold and Platinum subscribers get these companies with founder contact info and an outreach script — giving them a first-mover advantage before any competing buyer knows the deal exists.


About

Built by someone who knows where healthcare deals are made

I spent years in the healthcare industry placing talent and running large-scale projects for some of the most innovative companies in healthcare IT, pharma, and clinical technology. Along the way, I developed relationships with founders, operators, and executives across the entire healthcare ecosystem — the people who build these companies and eventually decide what comes next for them.

What I kept noticing was a gap. Founder-owned healthcare companies quietly exploring their exit — no banker, no listing, just signals — and PE firms, search funds, and strategic buyers with capital to deploy but no way to find them early enough to matter.

Quiet Healthcare Deals exists to close that gap. Every week I scan 40+ sources — LinkedIn, Hacker News, healthcare publications, and job boards — looking for the pre-market signals that indicate a founder is 6 to 12 months away from a transaction. Each company gets scored, sourced, and published before anyone else knows it's in play.

This is proprietary acquisition intelligence built on years of being inside the healthcare industry. Not a database. Not a scraper. A curated, human-verified signal service for serious buyers.


Pricing

Simple, deal-focused pricing

Cancel any time. No contracts. Upgrade when you find a deal worth acting on.

Silver
$99/mo
Full weekly digest
  • 3 scored opportunities every Friday
  • Acquisition score
  • Company overview & signals
  • Founder contact info
  • Outreach scripts
  • Full deal database
Subscribe →
Platinum
$499/mo
For PE firms & search funds
  • 3 scored opportunities every Friday
  • Warm founder introductions
  • Custom deal alerts
  • Geography & revenue filters
  • API access
  • Priority support
Subscribe →

Legal

Disclaimer & Liability

No Investment or Financial Advice. Quiet Healthcare Deals is an information and research service only. Nothing published on this website, in our newsletter, or in any related communication constitutes investment advice, financial advice, legal advice, or a recommendation to buy, sell, or acquire any company, security, or asset.

No Guarantee of Accuracy. Information presented — including company profiles, revenue estimates, acquisition scores, and signal analysis — is sourced from publicly available data. We make no representations or warranties as to the accuracy, completeness, or timeliness of any information published.

No Broker-Dealer Relationship. Quiet Healthcare Deals is not a registered broker-dealer, investment adviser, or M&A intermediary. We do not facilitate, negotiate, or represent any party in any transaction.

Limitation of Liability. To the fullest extent permitted by applicable law, Quiet Healthcare Deals, its owners, employees, and affiliates shall not be liable for any direct, indirect, incidental, or consequential damages arising from your use of this website or any information we publish.

Independent Verification Required. Subscribers are solely responsible for independently verifying all information before making any business or investment decision. We strongly recommend consulting with qualified legal, financial, and M&A advisors before pursuing any acquisition.

Intellectual Property. All content published by Quiet Healthcare Deals is proprietary and protected by copyright. Reproduction, distribution, or resale without written permission is strictly prohibited.

Last updated: July 2026. By subscribing to or using Quiet Healthcare Deals, you acknowledge that you have read, understood, and agree to this disclaimer in full.